Co-founder and CEO

TriAltus Bioscience, LLC


Mr. Shufflebarger is a life sciences industry veteran. He has more than 25 years’ experience in all facets of life science and technology businesses, from his earliest years working at the scientific bench to significant senior- and executive-management experience in directing operations, finance, and marketing; developing turnaround and recapitalization strategies, and initiating and completing licensing deals.

Shufflebarger was one of the first 15 employees hired at Atherotech Diagnostics Lab when he was named Director of Operations in 2000. For the next 16 years, he advanced to hold other crucial positions within the company including Finance Director, Vice President of Operations, and finally becoming Chief Operating Officer. During that time, he led Atherotech’s operational scale-up and increased capacity more than 100-fold. At its peak, the company generated more than $140 million in revenue.

His career also included managing marketing and business development activities for Birmingham-based Southern Research Institute—a preclinical drug development contract research organization—and holding technical positions at Southern Biotechnology Associates and at Avanti Polar Lipids, both privately-held specialty chemical manufacturers in Birmingham.

Shufflebarger earned a B.S. in Chemistry from Birmingham-Southern College and an MBA from Duke University. He was a member of the Board of Directors of the Birmingham Venture Club for 10 years, and served Board President in 2015 and 2016. He chaired the American Heart Association’s Heart Walk in 2015, which raised more than $500,000 in the Birmingham market.